JMIR Cancer

Patient-centered innovations, education, and technology for cancer care, cancer survivorship, and cancer research.

Editor-in-Chief:

Matthew Balcarras, MSc, PhD, Scientific Editor at JMIR Publications, Ontario, Canada


Impact Factor 2.7 CiteScore 5.9

JMIR Cancer (JC, ISSN: 2369-1999) is a peer-reviewed journal focusing on education, innovation and technology in cancer care, cancer survivorship and cancer research, and participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

We invite submissions of original research, viewpoints, reviews, tutorials, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but are free for others to use/implement). 

In our "Patients' Corner," we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer. In particular, we are interested in suggestions on improving the health care system and suggestions for new technologies, applications and approaches (this section has no article processing fees).

JMIR Cancer is indexed in PubMed Central and PubMedScopusDOAJ, MEDLINE, and the Emerging Sources Citation Index (Clarivate)

JMIR Cancer received a Journal Impact Factor of 2.7 according to the latest release of the Journal Citation Reports from Clarivate, 2025.

With a CiteScore of 5.9 (2024), JMIR Cancer is a Q2 journal in the field of Oncology, according to Scopus data.

Recent Articles

Article Thumbnail
Clinical Cancer Research

Renal cell carcinomas (RCCs) is a common, often letal kidney cancer that originates in the renal cortex. Its incidence is rising, and major factors include smoking, obesity, and hypertension, though its ethiology is uncertain. While surgery is effective for localized RCC, treatments for metastic RCC have advanced significantly due to better diagnostic, prognostic and predictive tools. Despite this progress, challenges remain, including long-term drug resistance and the complexity of RCC as a diverse group of diseases rather than a single entity.

|
Article Thumbnail
Emotional, Social, Psychological Support for Cancer

Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care.

|
Article Thumbnail
Nutrition, Physical Activity, Healthy Lifestyle for Cancer Patients and Survivors

Cancer survivors face significant challenges in maintaining adequate physical activity levels, which are essential for overall health and quality of life. Telehealth-based interventions offer promising opportunities to provide accessible support and promote healthier lifestyles throughout the cancer survivorship continuum. HealthScore is a telehealth coaching program designed to optimize the health of cancer survivors.

|
Article Thumbnail
Reviews on Innovations in Cancer

People surviving breast cancer often face long-term impairments in physical function, significantly impacting their quality of life. In recent years, a variety of technologies have been developed to monitor and assess these functions; however, there is no consolidated synthesis linking specific technologies to targeted functional domains and real-world clinical contexts, limiting comparability and translation into practice.

|
Article Thumbnail
Cancer Prognosis Models and Machine Learning

Immune checkpoint inhibitors (ICIs) have emerged as a pivotal treatment for advanced esophageal squamous cell carcinoma (ESCC). However, their efficacy can significantly differ among patients, highlighting the need for reliable prognostic markers to enhance treatment outcomes. Lactate dehydrogenase (LDH) plays a key regulatory role in the complex relationship between cancer metabolism and the immune system, suggesting that monitoring LDH levels may provide valuable insights into treatment efficacy and inform personalized therapeutic strategies for advanced ESCC.

|
Article Thumbnail
Innovations and Technology in Cancer Care

Barriers to eHealth usage include lack of technological infrastructure, resistance to change, and inequities in access. However, patterns of access and use of eHealth tools in people being treated for cancer have not been fully described in the literature.

|
Article Thumbnail
Cancer Prognosis Models and Machine Learning

Metastatic cancer remains one of the leading causes of cancer-related mortality worldwide. Yet, the prediction of survivability in this population remains limited by heterogeneous clinical presentations and high-dimensional molecular features. Advances in machine learning (ML) provide an opportunity to integrate diverse patient- and tumor-level factors into explainable predictive ML models. Leveraging large real-world datasets and modern ML techniques can enable improved risk stratification and precision oncology.

|
Article Thumbnail
Emotional, Social, Psychological Support for Cancer

Online cancer communities provide young adult (YA) cancer survivors with access to informational and emotional support that may not be available in traditional care settings. While these platforms offer vital connection opportunities, the unique pathways YA survivors take to find online communities and the challenges they encounter remain underexplored.

|
Article Thumbnail
Supporting Partners and Informal Caregivers of Cancer Patients

African American caregivers are more likely to be sole unpaid caregivers, spend more hours on caregiving tasks, and receive less external support compared to White caregivers; yet, limited research focuses on their specific needs. Even less attention has been paid to health care provider perspectives on how to better support this population, despite providers’ critical role in connecting caregivers to resources and implementing systems-level changes.

|
Article Thumbnail
Health Services Research in Oncology

Cancer patients often face significant financial challenges, known as financial toxicity (FT), which is associated with reduced quality of life. Patients with hematologic malignancies are especially vulnerable due to intensive and prolonged treatments, frequent hospital visits, and a high risk of complications. While FT affects many in the general population, it is particularly severe among racial and ethnic minorities, especially those below the poverty line. To our knowledge, no studies have specifically examined FT in this vulnerable group in the United States.

|

We are working in partnership with